Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend
BSE moved higher with 22 September in focus.
· LiveMint Markets
Mankind Pharma shares rose more than 2% in intraday trade on the BSE on Tuesday, 22 September, defying weak stock market sentiment. At the price of ₹2,481, Mankind Pharma stock has gained 10.4% in just four sessions.
Key facts
- Dates in focus
- 22 September
The analysis
BSE reported ₹2,481,, with movement of 2%, 10% and 10.4% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Why it matters
- With BSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads positive.
In this story
Related coverage
Stock Market Crash LIVE: Sensex Tanks Over 1,200 Points, Nifty 50 Below 22,200; ITC, JSW Steel, IndiGo Among Top Losers
INR vs USD: Rupee near 97/dollar; how TCS, Sun Pharma, Tata Steel, SRF may gain from weaker currency? Experts explain
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October
Valiant Organics among 5 commodity stocks that hit 52-week highs and rallied up to 48% in a month